Viewing Study NCT01152567

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-04-16 @ 7:00 PM
Study NCT ID: NCT01152567
Status: COMPLETED
Last Update Posted: 2011-09-27
First Post: 2010-06-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
None Cardiovascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hypertension View
None ACE View
None ARB View
None real life data View
None CVD View
None cost effectiveness View